A new study led by Clarkson University Associate Professor of Physical Therapy Kwadwo Appiah-Kubi introduces a virtual ...

People blinded by advanced dry age-related macular degeneration can now read books and recognize subway signs again, thanks ...

Key Points Interested in Belite Bio, Inc. Sponsored ADR? Here are five stocks we like better. Belite Bio highlighted positive ...

K8 slowed disease progression and trended towards improving visual acuity, which Inflammasome says warrants the drug’s further evaluation.

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well tolerat ...

Vonaprument reduced the proportion of eyes with clinically meaningful vision loss, though not uniformly across doses. Through ...

It’s a fine measure of the curator Joel Smith’s visual and emotional acuity that the first standout images one encounters on ...

Is there something to reduce leakage? Is there something in the blood-retinal barrier? Is there something that Ang2 or other ...

IRIS Registry analysis captured first faricimab injections from Feb 2022–Sep 2023, requiring ≥12 months pre-index data and ≥24 months follow-up to characterize longitudinal real-world utilization.

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...

Bausch + Lomb announced topline results from its phase 2 study of BL1107 in patients with glaucoma. According to the company, ...

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...